Dr. Ingles supports competitive decision making across several indications spanning oncology, pulmonology, rare diseases, and infectious diseases. Primary focus is given to indications with high unmet need, cutting-edge technologies, and next-generation drug development. Dr. Ingles attends all the major medical conferences in these disease areas throughout the year consistently engaging with top opinion leaders in the field.
Prior to joining inThought, Dr. Ingles conducted postdoctoral research in mechanisms of antibiotic resistance after completing her PhD in Microbiology and Molecular Genetics at Emory University as an NIH Ruth L. Kirschstein Predoctoral Fellow. Dr. Ingles doctoral research was performed in collaboration with the Cystic Fibrosis Center where she worked closely with researchers and physicians to advance life-changing therapies for people with CF.
While at Emory, Dr. Ingles was a member of the Emory Biotech Consulting Club where she performed conference coverage and developed market plans for technology being developed by Emory investigators.
